KCFA
AMGN icon

Key Client Fiduciary Advisors’s Amgen AMGN Stock Holding History

Key Client Fiduciary Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Buy
1,022
+2
+0.2% +$685 0.11% 157
2026
Q1 		$359K Sell
1,020
-20
-2% -$7.13K 0.12% 149
2025
Q4 		$340K Sell
1,040
-116
-10% -$36.8K 0.12% 145
2025
Q3 		$326K Sell
1,156
-3
-0.3% -$870 0.11% 157
2025
Q2 		$324K Buy
1,159
+10
+0.9% +$2.83K 0.13% 148
2025
Q1 		$358K Buy
1,149
+12
+1% +$3.54K 0.16% 132
2024
Q4 		$296K Buy
1,137
+17
+2% +$5.04K 0.13% 152
2024
Q3 		$361K Sell
1,120
-30
-3% -$9.81K 0.16% 131
2024
Q2 		$359K Buy
1,150
+16
+1% +$4.7K 0.18% 127
2024
Q1 		$323K Buy
1,134
+173
+18% +$50.6K 0.17% 131
2023
Q4 		$277K Sell
961
-47
-5% -$12.8K 0.16% 138
2023
Q3 		$271K Buy
1,008
+5
+0.5% +$1.25K 0.17% 133
2023
Q2 		$223K Buy
1,003
+35
+4% +$8.12K 0.13% 159
2023
Q1 		$234K Buy
968
+40
+4% +$9.82K 0.15% 148
2022
Q4 		$244K Buy
+928
New +$249K 0.16% 127

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Key Client Fiduciary Advisors's AMGN Position: Q2 2026 in Review

Key Client Fiduciary Advisors increased its Amgen (AMGN) stake by 0.2% in Q2 2026, buying an estimated $685 and bringing the position to 1,022 shares worth $370K. The position accounts for 0.11% of the portfolio, ranked #157.

Key Client Fiduciary Advisors first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Key Client Fiduciary Advisors held 1,022 shares of Amgen worth $370K as of Q2 2026.
  • Key Client Fiduciary Advisors bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.11% of Key Client Fiduciary Advisors's portfolio in Q2 2026, its #157 holding.
  • Key Client Fiduciary Advisors first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Key Client Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.